{"id":"W3027663151","doi":"10.1016/j.annonc.2020.05.012","title":"Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Sunnybrook Hospital","funders":"National Cancer Institute; National Institutes of Health; Puma Biotechnology; American Society of Clinical Oncology","keywords":"Medicine; Neratinib; Tolerability; Oncology; Breast cancer; Internal medicine; Stage (stratigraphy); Metastatic breast cancer; Cancer; Trastuzumab; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005853677,0.0001203247,0.0006733725,0.00004276368,0.00002564816,0.000004651961,0.00017002,0.0001197583,0.0003388728],"category_scores_gemma":[0.0002849328,0.00007605879,0.00008226469,0.0002563029,0.0003533685,0.00004810249,0.00004800604,0.0003841893,0.000001994674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008012859,"about_ca_system_score_gemma":0.000932429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003808029,"about_ca_topic_score_gemma":0.0007178985,"domain_scores_codex":[0.998225,0.0003997225,0.000490638,0.0002582574,0.0003321014,0.0002942662],"domain_scores_gemma":[0.9983855,0.0003523605,0.0002349068,0.0002521075,0.0006333676,0.0001417924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2800221,0.001956442,0.659934,0.0001907772,0.0002893461,0.00002195031,0.002792071,0.000052687,0.001402062,0.00006181624,0.001377531,0.05189915],"study_design_scores_gemma":[0.0907827,0.03414001,0.8695524,0.00008265003,0.00004648693,0.000001256525,0.0001857838,0.0003360501,0.002982181,0.00001307556,0.001774507,0.0001028946],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9615331,0.00006806348,0.0000122348,0.0351805,0.0000764158,0.001924361,0.0003495727,0.000007699162,0.0008479995],"genre_scores_gemma":[0.9967229,0.00003388708,0.0000353872,0.002864599,0.000167123,0.0001264229,0.00000900104,0.00001463596,0.00002606207],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2096184,"threshold_uncertainty_score":0.5756627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07013071804840221,"score_gpt":0.4039503543111601,"score_spread":0.3338196362627578,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}